Prostate cancer targeted MRI nanoprobe based on superparamagnetic iron oxide and copolymer of poly(ethylene glycol) and polyethyleneimin

Chinese Science Bulletin

Volumn 54, Issue 18, 2009, Pages 3137-3146

  Zhou, JianHua ^a   Huang, Lü ^b   Wang, WeiWei ^b   Pang, Jun ^a   Zou, Yang ^a   Shuai, XinTao ^b   Gao, Xin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Magnetic resonance imaging (MRI); PEG grafted hyperbranched PEI (PEG g PEI); Prostate cancer (PCa); Prostate stem cell antigen (PSCA); Superparamagnetic iron oxide nanoparticles (SPIO)

Indexed keywords

EID: 77958462083     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-009-0256-6     Document Type: Article

References (31)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics. CA Cancer J Clin, 2005, 55: 10-30
2. Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med, 2004, 351: 1502-1512
3. Men S, Cakar B, Conkbayir I, et al. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. J Exp Clin Cancer Res, 2001, 20: 473-480
4. Inahara M, Suzuki H, Kojima S, et al. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings. Urology, 2006, 68: 815-819
5. Gupta NP, Ansari MS, Dass SC. Transrectal ultrasound guided biopsy for detecting early prostate cancer: An Indian experience. Indian J Cancer, 2005, 42: 151-154
6. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol, 2000, 164: 400-404
7. Batllea C, Vilanova-Busquets JC, Saladié-Roigc JM, et al. The value of endorectal MRI in the early diagnosis of prostate cancer. Eur Urol, 2003, 44: 201-208
8. Villers A, Puech P, Leroy X, et al. Dynamic contrast-enhanced MRI for preoperative identification of localised prostate cancer. European Urology Suppl, 2007, 6: 525-532
9. Pintaske J, Helms G, Bantleon R, et al. A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labeled cells by MRI. Biomed Tech (Berl), 2005, 50: 174-180
10. Wagner S, Schnorr J, Pilgrimm H, et al. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: Preclinical in vivo characterization. Invest Radiol, 2002, 37: 167-177
11. Okassa L N, Marchais H, Douziech-Eyrolles L, et al. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles. Eur J Pharm Biopharm, 2007, 67: 31-38
12. Mohapatra S, Pramanik N, Ghosh SK, et al. Synthesis and characterization of ultrafine poly(vinylalcohol phosphate) coated magnetite nanoparticles. J Nanosci Nanotechnol, 2006, 6: 823-829
13. Fessi H. Preparation, characterization and surface study of poly-ep-silon caprolactone magnetic microparticles. J Colloid Interface Sci, 2006, 300: 584-590
14. Liang S, Wang Y, Yu J, et al. Surface modified superparamagnetic iron oxide nanoparticles: As a new carrier for bio-magnetically targeted therapy. J Mater Sci Mater Med, 2007, 18: 2297-2302
15. Lee H, Lee E, Kim DK, et al. Antibiofouling polymer-coated super-paramagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J Am Chem Soc, 2006, 128: 7383-7389
16. Tian H, Chen X, Lin H, et al. Micellization and reversible pH-senstive phase transfer of the hyperbranched multiarm PEI-PBLG copolymer. Chemistry, 2006, 12: 4305-4312
17. Kim JY, Lee JE, Lee SH, et al. Designed fabrication of multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically-guided drug delivery. Adv Mater, 2008, 20: 478-483
18. Boutry S, Laurent S, Elst LV, et al. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol Imaging, 2006, 1: 15-22
19. Liang S, Wang Y, Yu J, et al. Surface modified superparamagnetic iron oxide nanoparticles: As a new carrier for bio-magnetically targeted therapy. J Mater Sci Mater Med, 2007, 18: 2297-2302
20. Li Y, Xu X, Deng C, et al. Immobilization of trypsin on superpara-magnetic nanoparticles for rapid and effective proteolysis. J Proteome Res, 2007, 6: 3849-3855
21. Park IK, Ng CP, Wang J, et al. Determination of nanoparticle vehicle unpackaging by MR imaging of a T(2) magnetic relaxation switch. Biomaterials, 2008, 29: 724-732
22. Gupta AK, Gupta M. Synthesis and surface engineering of iron ox-ide nanopartides for biomedical applications. Biomaterials, 2005, 26: 3995-4021
23. Lam JS, Yamashiro J, Shintaku IP, et al. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res, 2005, 11: 2591-2596
24. Morgenroth A, Cartellieri M, Schmitz M, et al. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-Cells. Prostate, 2007, 67: 1121-1131
25. Garcia-Hernandez Mde L, Gray A, Hubby B, et al. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res, 2008, 68: 861-869
26. Sun S, Zeng H, Robinson DB, et al. Monodisperse MFe2O4(M = Fe, Co, Mn) nanoparticles. J Am Chem Soc, 2004, 126: 273-279
27. Tromsdorf UI, Bigall NC, Kaul MG, et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett, 2007, 7: 2422-2427
28. Shen XM. N-maleimidly Polymer Derivatives. US Patent, US0013797 A1, 2006-01-19
29. Shuai X, Merdan T, Unger F, et al. Novel biodegradable ternary co-polymers hy-PEI-g-PCL-b-PEG: Synthesis, characterization, and potential as efficient nonviral gene delivery vectors. Macromolecules, 2003, 36: 5751-5759
30. Greg TH. Bioconjugate Techniques. New York: Academic Press, 1996. 463-464
31. Kuhn DM, Balkis M, Chandra J, et al. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Mi- crobiol, 2003, 41: 506-508